Chi‐Jing Choong

1.1k total citations
25 papers, 816 citations indexed

About

Chi‐Jing Choong is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Chi‐Jing Choong has authored 25 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 12 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Chi‐Jing Choong's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological disorders and treatments (6 papers) and Alzheimer's disease research and treatments (5 papers). Chi‐Jing Choong is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological disorders and treatments (6 papers) and Alzheimer's disease research and treatments (5 papers). Chi‐Jing Choong collaborates with scholars based in Japan, United States and Malaysia. Chi‐Jing Choong's co-authors include Hideki Mochizuki, Kousuke Baba, Hideki Hayakawa, Yoshitaka Nagai, Yuji Goto, Harutoshi Fujimura, Katsuya Araki, Naoto Yagi, Toru Yasuda and Yee‐How Say and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Chi‐Jing Choong

25 papers receiving 809 citations

Peers

Chi‐Jing Choong
Alexey V. Berezhnov Russia
Giulia Ambrosi Italy
Simona Eleuteri United States
Sun Young Chung United States
Thomas W. Rösler Germany
Jeong Sook Kim‐Han United States
Géraldine Gelders Belgium
Yoon‐Seong Kim United States
Jahan Ara United States
Roberta Filograna Sweden
Alexey V. Berezhnov Russia
Chi‐Jing Choong
Citations per year, relative to Chi‐Jing Choong Chi‐Jing Choong (= 1×) peers Alexey V. Berezhnov

Countries citing papers authored by Chi‐Jing Choong

Since Specialization
Citations

This map shows the geographic impact of Chi‐Jing Choong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Jing Choong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Jing Choong more than expected).

Fields of papers citing papers by Chi‐Jing Choong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Jing Choong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Jing Choong. The network helps show where Chi‐Jing Choong may publish in the future.

Co-authorship network of co-authors of Chi‐Jing Choong

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Jing Choong. A scholar is included among the top collaborators of Chi‐Jing Choong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Jing Choong. Chi‐Jing Choong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikenaka, Kensuke, Yuta Kajiyama, Chi‐Jing Choong, et al.. (2024). Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients. Pharmacology Research & Perspectives. 12(1). e1174–e1174. 6 indexed citations
2.
Choong, Chi‐Jing & Hideki Mochizuki. (2023). Involvement of Mitochondria in Parkinson’s Disease. International Journal of Molecular Sciences. 24(23). 17027–17027. 27 indexed citations
3.
Kimura, Yasuyoshi, Toshihide Takeuchi, Chi‐Jing Choong, et al.. (2022). Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson’s disease. Scientific Reports. 12(1). 351–351. 25 indexed citations
4.
Mochizuki, Hideki, Chi‐Jing Choong, & Kousuke Baba. (2020). Parkinson’s disease and iron. Journal of Neural Transmission. 127(2). 181–187. 87 indexed citations
5.
Baba, Kousuke, Tatsusada Okuno, Makoto Kinoshita, et al.. (2020). Go-sha-jinki-Gan Alleviates Inflammation in Neurological Disorders via p38-TNF Signaling in the Central Nervous System. Neurotherapeutics. 18(1). 460–473. 9 indexed citations
6.
Choong, Chi‐Jing, Tatsusada Okuno, Kensuke Ikenaka, et al.. (2020). Alternative mitochondrial quality control mediated by extracellular release. Autophagy. 17(10). 2962–2974. 73 indexed citations
7.
Tada, Satoru, Tatsusada Okuno, Yoshiki Sakai, et al.. (2019). Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis. Scientific Reports. 9(1). 5252–5252. 11 indexed citations
8.
Choong, Chi‐Jing, Masayuki Nakamori, Hideki Hayakawa, et al.. (2019). Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson’s disease. Scientific Reports. 9(1). 7567–7567. 77 indexed citations
9.
Hayakawa, Hideki, Kensuke Ikenaka, Chi‐Jing Choong, et al.. (2019). Structurally Distinct α‐Synuclein Fibrils Induce Robust Parkinsonian Pathology. Movement Disorders. 35(2). 256–267. 24 indexed citations
10.
Mochizuki, Hideki, Chi‐Jing Choong, & Eliezer Masliah. (2018). A refined concept: α-synuclein dysregulation disease. Neurochemistry International. 119. 84–96. 25 indexed citations
11.
Hirata, Yoshiyuki, Tsutomu Sasaki, Hideaki Kanki, et al.. (2018). New 5-Aryl-Substituted 2-Aminobenzamide-Type HDAC Inhibitors with a Diketopiperazine Group and Their Ameliorating Effects on Ischemia-Induced Neuronal Cell Death. Scientific Reports. 8(1). 1400–1400. 18 indexed citations
12.
Choong, Chi‐Jing & Hideki Mochizuki. (2016). Gene therapy targeting mitochondrial pathway in Parkinson’s disease. Journal of Neural Transmission. 124(2). 193–207. 24 indexed citations
13.
Choong, Chi‐Jing, Tsutomu Sasaki, Hideki Hayakawa, et al.. (2015). A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease. Neurobiology of Aging. 37. 103–116. 42 indexed citations
14.
Choong, Chi‐Jing, Kousuke Baba, & Hideki Mochizuki. (2015). Gene therapy for neurological disorders. Expert Opinion on Biological Therapy. 16(2). 143–159. 54 indexed citations
15.
Araki, Katsuya, Naoto Yagi, Yuka Ikemoto, et al.. (2015). Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients. Scientific Reports. 5(1). 17625–17625. 79 indexed citations
16.
Tada, Satoru, Tatsusada Okuno, Yasumichi Hitoshi, et al.. (2014). Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis. Journal of Neuroinflammation. 11(1). 179–179. 10 indexed citations
17.
Yasuda, Toru, et al.. (2013). Neurodegenerative changes initiated by presynaptic dysfunction. Translational Neurodegeneration. 2(1). 16–16. 26 indexed citations
18.
Mochizuki, Hideki, Chi‐Jing Choong, & Toru Yasuda. (2013). The promises of stem cells: stem cell therapy for movement disorders. Parkinsonism & Related Disorders. 20. S128–S131. 12 indexed citations
19.
20.
Choong, Chi‐Jing & Yee‐How Say. (2011). Knockdown of α-Synuclein Enhances Susceptibility to Staurosporine-Induced Apoptosis in Human Melanoma SK-MEL28 Cells. Journal of Biological Sciences. 11(2). 135–145. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexey V. Berezhnov Breakdown of academic impact, for papers by Giulia Ambrosi Breakdown of academic impact, for papers by Simona Eleuteri Breakdown of academic impact, for papers by Sun Young Chung Breakdown of academic impact, for papers by Thomas W. Rösler Breakdown of academic impact, for papers by Jeong Sook Kim‐Han Breakdown of academic impact, for papers by Géraldine Gelders Breakdown of academic impact, for papers by Yoon‐Seong Kim Breakdown of academic impact, for papers by Jahan Ara Breakdown of academic impact, for papers by Roberta Filograna
Rankless by CCL
2026